Inactive

SUBJECT: The U.S. Army Medical Materiel Development Activity (USAMMDA), Warfighter Protection and Acute Care Project Management Office (WPAC PMO) of the U.S. Army Medical Research and Development Comm... SUBJECT: The U.S. Army Medical Materiel Development Activity (USAMMDA), Warfighter Protection and Acute Care Project Management Office (WPAC PMO) of the U.S. Army Medical Research and Development Command (USAMRDC) is conducting market research to identify organizations developing a whole blood pathogen reduction technology that meets requirements of the Department of Defense (DoD). This market research may also assist with the further development and/or refinement of the requirements. DISCLAIMER: In accordance with Federal Acquisition Regulation (FAR) 15.201 "Exchange with industry before receipt of proposals, "this Request for Information (RFI) is for information and planning purposes only at this time, and shall not be construed as a solicitation or as an obligation on the part of the USAMRDC, or collaborative DoD activities. Neither unsolicited proposals nor any other kind of offers will be considered in response to this RFI. Responses to this notice are not offers and will not be accepted by the Government to form a binding contract. In keeping with the standards of FAR Part 10, the Government may request additional information from responders. Responders are solely responsible for all expenses associated with responding to this RFI or any follow-up information request. All information received in response to this RFI or any follow-up information request that is marked Proprietary will be handled accordingly. Responses to the RFI will not be returned. At this time, questions concerning the composition and requirements for a future request for proposal will not be entertained. Please read the RFI and attachments for further details.